NDC 70518-4402-00 - Levothyroxine sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4402
- Requested NDC
- 70518-4402-00
- Package NDCs from labels
- 70518-4402-0, 70518-4402-00
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-09-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine sodium - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-09-10 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4402-0 | Levothyroxine sodium | 90 in 1 BOTTLE | TABLET | 90 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | db9821db-3fe3-d1cf-e053-2a95a90a0252 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | da570872-94a1-4852-e053-2995a90aacb6 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ANDA212399 892246 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | da827567-810b-624d-e053-2a95a90a9bde | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f86fab39-bbd9-a51c-e053-6294a90accd0 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966220 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | d9dff641-ced3-bae3-e053-2a95a90a2e29 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 472ec9e7-c1db-bf8c-e063-6394a90a2c07 | 2025-12-30 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| Dem Zero | PHOSPHATIDYLSERINE, MAGNESIUM OXIDE | NPG Bio Pharmaceuticals Co.,Ltd. | 411f1a0f-ed02-cc78-e063-6394a90a0aec | 2025-12-18 | Warnings | 3A3U0GI71G |
| Alzh L | PHOSPHATIDYLSERINE, MAGNESIUM OXIDE | NPG Bio Pharmaceuticals Co.,Ltd. | 41056de0-aaa2-01bb-e063-6394a90af7b8 | 2025-12-18 | Warnings | 3A3U0GI71G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | e3667ab1-2bd9-4e0d-8a97-f907593e7954 | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 966248 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | eb120047-a43b-40a4-9f55-067b1b51edda | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 966248 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 2adb05ef-b3fa-4ac2-b219-99442746392b | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | 966270 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | d5b005e8-a88d-450b-bbc3-393d885260f5 | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | 966270 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | c29a417b-95b0-4c9b-85e6-ec884049edb1 | 2025-12-02 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966222 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 3453af75-8c2e-421f-9a08-24751936df41 | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966225 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 1af49c9f-93da-4838-899b-9445083a154b | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966225 9J765S329G |
| Prenate Chewable | CALCIUM CARBONATE, CHOLECALCIFEROL, MAGNESIUM OXIDE, BORON, FOLIC ACID, LEVOMEFOLATE GLUCOSAMINE, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, BIOTIN AND BLUEBERRY | Avion Pharmaceuticals, LLC | 917f02ce-51b9-4819-81e0-522842f6732a | 2025-11-25 | Adverse reactions | 3A3U0GI71G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | fea284d8-0514-498b-a37c-405730b5f6a2 | 2025-11-18 | Boxed warning, Warnings, Adverse reactions | 966270 9J765S329G |
| Magnesium Oxide | MAGNESIUM OXIDE | Marlex Pharmaceuticals Inc | 0bb322a5-fb92-14de-e063-6294a90a4c1b | 2025-11-14 | Warnings | 3A3U0GI71G |
| magnesium oxide | MAGNESIUM OXIDE | Marlex Pharmaceuticals Inc. | dc57893c-068a-37d8-e053-2a95a90aa054 | 2025-11-14 | Warnings | 3A3U0GI71G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 4302e36f-0b5b-f645-e063-6394a90a010f | 2025-11-07 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.